In summary, we have demonstrated that LBW, a known risk factor for development of insulin resistance and type 2 diabetes, is associated with multiple defects in the PI3K/Akt pathway under basal conditions and following in vivo insulin-stimulation. The gene discussed is AKT1; the disease is type 2 diabetes mellitus.